Families looking at communities for a parent with memory loss tend to encounter the phrase “memory care” before any other. It appears in brochures and on websites, in the first ten minutes of every tour. The phrase implies something specific: a clinical apparatus, a specialized program, treatment organized around the science of dementia. Sometimes that’s what it is. Often it isn’t.
In most U.S. states, “memory care” is a regulatory category, not a clinical one. Legally, it requires a secured unit where residents with dementia can be safely contained, with somewhat higher staffing ratios than standard assisted living. That is the whole of it. Two communities, both licensed, can deliver entirely different experiences. One may have an engaged medical director, programming built around the published evidence, and individualized care plans aimed at slowing decline. The other may offer little more than locked doors and a higher monthly rate.
This matters because the science has changed. The 2024 Lancet Commission on dementia prevention estimates that close to half of all dementia worldwide could be prevented or delayed through lifestyle and medical interventions, and a growing body of research suggests that many of those same interventions continue to slow decline after symptoms have begun. Families have far more leverage than they tend to realize, provided they know what to ask.
The conventional wisdom for decades was that once dementia began, the trajectory was fixed. Newer research has dismantled that picture, and the evidence is now strong enough that any community claiming to specialize in cognitive care ought to be acting on it.
Two large randomized trials have done the most to shift this thinking.
- The FINGER trial in Finland. Beginning in 2009, researchers enrolled 1,260 older adults at risk of dementia into a structured two-year program combining diet, exercise, brain training, social activity, and treatment of vascular risk factors (high blood pressure, cholesterol, and blood sugar). Participants showed measurable cognitive improvement against a usual-care control, and long-term follow-up has shown the benefit persists for more than a decade.
- The U.S. POINTER trial. Results released in 2025 from a 2,000-person study across five U.S. sites confirmed and extended FINGER’s findings. Two versions of the lifestyle program both improved cognition, with the more structured version producing the larger gain. The benefit held across men and women, across racial and ethnic groups, and among people carrying the higher-risk APOE4 genetic variant.
Taken together, these trials establish something families rarely hear from their geriatricians: cognitive decline isn’t a one-way street. Cardiovascular care, regular physical activity, treatment of sleep disorders, attention to depression, and sustained social engagement all of these continue to produce measurable cognitive benefit even after symptoms have begun.
Which reframes the question for families. It isn’t only whether a memory care unit can safely house their parent. It’s whether the community is actually doing the things the evidence says can slow what comes next.
What to look for in a community
A locked door is a safety measure, not a treatment. The communities worth choosing are doing harder and largely invisible work. Almost none of it appears in the brochure. Most of it can be surfaced on a tour, with the right questions.
A few questions tend to separate the communities that take cognitive care seriously from the ones that don’t:
- Who oversees medical care, and how often are they on-site? Ask how regularly blood pressure, cholesterol, blood sugar, and weight are checked, and what happens when one of them drifts.
- What does physical activity actually look like, day to day? Walking groups are universal. Strength training, with weights, bands, or machines, is much less common. Maintaining muscle is among the strongest protections against both physical and cognitive decline in later life.
- How are hearing and vision handled? Untreated sensory impairment is a major and underrecognized driver of cognitive decline. Ask whether hearing and vision are tested at move-in and annually, who’s responsible for managing hearing aids and glasses, and whether an audiologist or eye doctor visits the community on-site.
- How is depression handled? Late-life depression is common, frequently missed, and an established risk factor for dementia. Ask whether residents are screened, who manages mental-health care, and what happens when a resident’s mood shifts noticeably.
- How is sleep handled? Ask about overnight protocols, lighting, and whether sleep apnea is screened for at intake. Communities that treat sleep as clinical care rather than comfort are doing what the current evidence recommends.
- How does the community measure social engagement? Activity calendars are easy to print. Knowing whether a specific resident is actually attending is harder. A small number of communities now track individual engagement and adjust programming when someone starts to withdraw.
- Who is the medical director, and how often are they actually on-site? Ask how often the medical director sees residents, and how care gets coordinated with outside doctors.
If the answers to these questions are vague, that’s information too.
What’s on the horizon
A small but growing number of senior living operators are rebuilding their cognitive-care offerings around the research. Some have hired geriatricians or behavioral neurologists into operational leadership. Others have partnered with universities and academic medical centers to bring research-grade protocols into daily care. A handful have begun publishing outcomes data, which was almost unheard of in this industry until recently.
These shifts are uneven, and they aren’t always easy to spot from the outside. But on a tour, families can ask whether the community partners with any academic medical center, whether it tracks outcomes of any kind, and whether its programming is grounded in published research. The answers reveal which direction the operator is facing.
The bottom line
A brochure tells you very little. What tells you something is what the community does day to day: how it manages medical care, whether it treats sensory and sleep problems, how it builds physical activity and social engagement into the daily routine, and whether its medical leadership is engaged enough to keep pushing on those things.
None of it is optional. On the current evidence, it’s the substance of cognitive care in later life. Your parent deserves to be in a place that’s doing the work, and you have every right to keep asking until you can tell whether it is.
References
- Livingston G, Huntley J, Liu KY, et al. Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission. The Lancet. 2024;404(10452):572-628.
- Ngandu T, Lehtisalo J, Solomon A, et al. A 2-year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. The Lancet. 2015;385(9984):2255-2263.
- Ngandu T, Lehtisalo J, Levälahti E, et al. Long-term adherence to lifestyle changes and association with cognitive change: 11-year results from the FINGER randomized, controlled trial. Alzheimer’s & Dementia. 2025.
- Baker, Laura D., et al. Structured vs self-guided multidomain lifestyle interventions for global cognitive function: the US POINTER randomized clinical trial. JAMA. (2025): 681-691.
- Kivipelto M, Mangialasche F, Snyder HM, et al. World-Wide FINGERS Network: a global approach to risk reduction and prevention of dementia. Alzheimer’s & Dementia. 2020;16(7):1078-1094.
